Origami Paper-based tecHnology fOr the innovativE aNd sustaInable Organ-on-Chip devices
The PHOENIX-OoC project aims to revolutionize Organ-on-Chip technology by developing origami paper-based devices for cell co-cultures and pharmacological studies, enhancing sustainability and functionality.
Projectdetails
Introduction
Sustainability is one of the most important concepts nowadays, being able to drive activities in several sectors, namely environment preservation, society, and economy. In Analytical Chemistry, the development of sustainable devices was boosted by the introduction of microfluidic paper-based analytical devices (PADs) whose advantages, however, are not only confined to the concept of sustainability.
Features of Paper-based Devices
Indeed, paper as a functional material confers unprecedented features to PADs. However, paper-based devices remain exploited as only analytical tools and have not (yet) been adopted by the Organ-on-Chip (OoC) world. The objective of the present project proposal is to alter this scenario.
Project Goals
In PHOENIX-OoC, we will radically change the OoC field by making use of paper's versatile properties and develop OoC devices using paper in origami configuration. The specific aims include:
- Cell Co-cultures: To better simulate different organ tissues.
- (Bio)sensors Integration: For on-site/continuous monitoring of cells' status/response to stimuli.
- Pharmacological Studies: To perform accurate pharmacological studies.
Innovative Technology
The main new idea is the introduction of a technology that can deliver a versatile set of electrochemical devices with new functionalities. This will enable the creation of ready-to-use cell culture models for drug screenings in a custom-made manner.
Consortium Collaboration
Because OoC is a complex system with respect to PADs, partners with different and needed skills have been gathered among the most important European scientists/entities in the field required. The PHOENIX-OoC consortium brings together:
- 6 partners
- 4 Universities
- 1 research organization
- 1 industrial partner (1 SME)
These partners include 5 from 4 EU (associated) countries (Italy, Sweden, Spain, Serbia) and 1 non-EU member: Switzerland, which are renowned experts in the world on paper-based biosensors, in vitro/vivo studies, modelling, microfluidics, biomaterials, and joint tissue engineering.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.202.333 |
Totale projectbegroting | € 2.202.333 |
Tijdlijn
Startdatum | 1-3-2024 |
Einddatum | 28-2-2027 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATApenvoerder
- FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA
- UPPSALA UNIVERSITET
- UNIVERZITET U NOVOM SADU FAKULTET TEHNICKIH NAUKA
- SENSE4MED S.R.L.
- UNIVERSITAT BASEL
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancyThe PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance. | EIC Pathfinder | € 2.982.792 | 2022 | Details |
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation. | EIC Pathfinder | € 2.996.550 | 2022 | Details |
Smart Electronic Olfaction for Body Odor DiagnosticsSMELLODI aims to digitize and synthesize olfactory information for remote disease diagnostics and assist individuals with olfactory disorders using advanced sensor technology and machine learning. | EIC Pathfinder | € 3.263.781 | 2022 | Details |
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images. | EIC Pathfinder | € 2.744.300 | 2022 | Details |
A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy
The PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance.
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"
The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.
Smart Electronic Olfaction for Body Odor Diagnostics
SMELLODI aims to digitize and synthesize olfactory information for remote disease diagnostics and assist individuals with olfactory disorders using advanced sensor technology and machine learning.
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.
The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Paving the way for High-throughput Organoid ENgineering using Integrated acoustiXPHOENIX aims to develop a microfluidic technology for high-throughput generation of vascularized cerebral organoids, enhancing reproducibility and maturation through acoustophoresis and two-photon writing. | ERC COG | € 2.832.500 | 2023 | Details |
Evolving Organs-on-Chip from developmental engineering to “mechanical re-evolution”EvOoC develops smart Organs-on-Chip platforms that utilize mechanical forces and machine learning to enhance tissue regeneration and disease modeling for innovative therapeutic solutions. | ERC STG | € 2.430.625 | 2023 | Details |
High Throughput Modelling and Measurement of Human Epithelial Models using Electrospun Conducting Polymers For Unlocking Data-Driven Drug DiscoveryThe project aims to enhance drug discovery by developing simplified Organ on Chip platforms through hydrogel electrospinning, enabling scalable monitoring and integration into industry workflows. | ERC POC | € 150.000 | 2025 | Details |
PRECISIONDit project onderzoekt het gebruik van 3D-printing om de beperkingen van fotolithografie bij de productie van organ-on-chip modellen te overwinnen voor geneesmiddelentests en biologieonderzoek. | MIT Haalbaarheid | € 20.000 | 2022 | Details |
Paving the way for High-throughput Organoid ENgineering using Integrated acoustiX
PHOENIX aims to develop a microfluidic technology for high-throughput generation of vascularized cerebral organoids, enhancing reproducibility and maturation through acoustophoresis and two-photon writing.
Evolving Organs-on-Chip from developmental engineering to “mechanical re-evolution”
EvOoC develops smart Organs-on-Chip platforms that utilize mechanical forces and machine learning to enhance tissue regeneration and disease modeling for innovative therapeutic solutions.
High Throughput Modelling and Measurement of Human Epithelial Models using Electrospun Conducting Polymers For Unlocking Data-Driven Drug Discovery
The project aims to enhance drug discovery by developing simplified Organ on Chip platforms through hydrogel electrospinning, enabling scalable monitoring and integration into industry workflows.
PRECISION
Dit project onderzoekt het gebruik van 3D-printing om de beperkingen van fotolithografie bij de productie van organ-on-chip modellen te overwinnen voor geneesmiddelentests en biologieonderzoek.